Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 4 | History Defined

US Senate Narrowly Votes In Favor Of Biden's Nominee Robert Califf To Lead FDA For Second Time

By a narrow vote of 50-46, the Senate has confirmed Robert Califf to run the FDA.

Senate confirms Robert Califf to become Biden’s FDA commissioner

WASHINGTON — The Senate on Tuesday confirmed Robert Califf to lead the Food and Drug Administration, 50-46, a much narrower vote than when he previously held the position during the Obama administration, though many thought the latest vote could be even closer.

Tribune News Service

Senate confirms Robert Califf as FDA commissioner

Senate confirms Robert Califf as FDA commissioner

The agency has been without a permanent leader for more than a year.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Senate confirms Califf to become Biden's FDA commissioner - Roll Call

Six Republicans voted Tuesday to confirm FDA nominee Robert Califf, who had seen opposition from pockets of the Democratic caucus.

Jury finds New York Times did not defame Sarah Palin – as it happened

Former Republican vice-presidential nominee sued the newspaper in 2017 claiming an editorial damaged her career

The Guardian - US

Senate sets up Califf confirmation vote with narrow procedural win - Roll Call

The nominee to lead the FDA, Robert Califf, survived a Senate procedural vote Monday with the help of five Republicans.

FDA's agenda in limbo as Biden's nominee stalls in Senate

President Joe Biden’s pick to lead the powerful Food and Drug Administration has stalled in the narrowly divided Senate

The Independent UK

inkl

Read news from The Economist, FT, and more,
with one subscription

Wyden probes FDA nominee’s views on accelerated drug approvals

WASHINGTON — Senate Finance Chair Ron Wyden, D-Ore., is pressing the White House’s nominee to lead the Food and Drug Administration, Robert Califf, to pledge to crack down on drugmakers’ use of fast-track approval pathways as the nominee seeks the chairman’s support.

Tribune News Service

Wyden probes FDA nominee's views on accelerated drug approvals - Roll Call

Wyden probes FDA nominee's views on accelerated drug approvals - Roll Call

Support from Wyden could be crucial to Robert Califf's FDA confirmation amid concerns from other Senate Democrats.

1 2 3 4

People

Marsha Blackburn

Sarah Bloom Raskin

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Food and Drug Administration

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

379,521 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play